Sudarshan Chemical gets Positive outlook at IND AA on Heubach EBITDA

The ratings Ind-Ra affirmed

Heubach acquisition behind the outlook change

Ind-Ra ties the change to the Heubach acquisition, which Sudarshan completed in March 2025. The agency says the deal made the company the second-largest pigment producer globally, with 19 facilities across five continents. Ind-Ra expects a sustained rise in EBITDA from the acquired business, together with the sale of the non-core VP4 Frankfurt GmbH plant, to result in a "net debt neutral position" at the consolidated level by end-FY27. Net debt is borrowings less cash, so that position means cash and borrowings net to zero.

FY26 after the Heubach deal

Consolidated revenue for FY26 was ₹9,787 crore, nearly three times the FY24 level. The Heubach group contributed ₹7,000 crore of that total, and the legacy pigment business was flat at ₹2,600 crore. Consolidated EBITDA, meaning earnings before interest, tax, depreciation and amortisation, excluding other income, was ₹589 crore against ₹381 crore in FY25. The EBITDA margin fell to 6.0% from 11.4%. The acquired business generated EUR13 million of EBITDA, below its guidance of EUR35 million, which Ind-Ra attributes to higher-than-expected inventories. Integration costs were about ₹130 crore in FY26.

VP4 Frankfurt stake sale

Sudarshan is selling its stake in VP4 Frankfurt GmbH, a step-down wholly owned subsidiary, for a consideration of EUR76.5 million, which Ind-Ra gives as ₹840 crore. Ind-Ra says the sale is likely to complete in 3QFY27 and that the proceeds will largely go to prepaying acquisition debt, meaning repaying loans before their due dates.

Rating sensitivities

Ind-Ra states one trigger in each direction. A positive rating action can result from a sustained increase in scale and profitability, with net adjusted leverage, including letter of credit acceptances, below 1.0x on a sustained basis. A negative one is weaker-than-expected growth and profitability, or higher capex or working capital, leaving net leverage including acceptances above 1.0x on a sustained basis, which could lead to the outlook being revised to Stable. Net leverage including acceptances was 1.4x in FY26, against 2.0x in FY25.

What the outlook change means for Sudarshan Chemical's shareholders

The change is to the outlook on the debt, not to the ratings. The bank loan facilities stay at IND AA, the fixed deposits at IND AA and the commercial paper at IND A1+. A Positive outlook is Ind-Ra's indication of the direction a rating may take over the medium term, and it is not an upgrade. In the quarter ended 30 Jun 2026 (Q1 FY27), consolidated revenue was ₹2,661.1 crore and net profit ₹103.4 crore. The notice does not say when Ind-Ra will next review the ratings or give a dated next step. The share closed at ₹1,121.70 on 19 Oct 2026.

Reference: Original filing (PDF)